Weekly Roundup: Renewed AI Concerns Weigh on the Market and Portfolio
We added to six holdings, and upgraded and lifted a price target on another as favorable AI data conflicted with market emotion.
We added to six holdings, and upgraded and lifted a price target on another as favorable AI data conflicted with market emotion.
Customer spending plans drive one move, while the domestic manufacturing economy does the other.
Elon Musk’s latest move could signal the future of telecom. Here’s how I’m trading the initial reaction.
Meta’s 2-for-1 split comes with a catch. Here’s what to know and how I’m playing it.
Amex delivers, OpenAI’s capital raise and a potential one for Meta. Plus other headlines moving the market this morning.
As more and more funds are raised for the AI buidout, is there a scarcity of capital?
Thursday’s selloff isn’t a signal to cut exposure. It is a signal to look where the money is going.
We aim to play the long game with the shares, but here’s what the market focus will be near term.
The AI complex is getting hit on earnings while small caps, biotech, retail and defensive pharma hold up. Here’s what I’m buying.
As Rocket Labs teases, I’m buying more, but lowering my expectations.